Many people experience gradual weight loss while using GLP-1 medications, with the rate of progress varying based on individual factors and lifestyle
Nevertheless, AP/NTS neurons seem to be a major target of GLP-1R agonists which are more stable in the bloodstream [49, 50]
Study: Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study
NANNA, SARA TABTABAI, Association Between Semaglutide 2.4 mg and Risk of Cardiovascular Events in Patients With Heart Failure in the Real World: Results From the SCORE-HF Study, Journal of Cardiac Failure - Intersections, 10.1016/j.yjcafi.2026.05.004, (2026)
One component, glabridin, has extra potent antioxidant and soothing properties
Consistent with other GLP1R agonists, nausea, diarrhea and vomiting are common side-effects, with no long-term harms noted from Trulicity over its 9 year use in the markets